breastfeeding and semaglutide Subcutaneous during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk Semaglutide and Breastfeeding Safety |

The retrospective cohort study by Orandi et al., recently published in The Lancet Diabetes & Endocrinology , offers compelling evidence on the effectiveness and safety of glucagon-like peptide-1 (GLP-1) receptor agonists in kidney transplant recipients with pre-existing type 2 diabetes (1)

Pricing Sections Weight Loss Program Pricing Weight Loss Consultations & Follow-Ups Every successful weight loss journey starts with the right plan

Flow Wellness utilizes body composition analysis to help patients track changes in body fat, muscle mass, and visceral fat throughout their wellness journey

In the simple, preliminary model with only linear effect of time on GLP-1 RA and duration of HH, exposure to GLP-1 RA for 1 year was associated with around 30% (95% CI 20% to 40%) lower estimated ferritin levels